254 related articles for article (PubMed ID: 28427240)
1. UBE2T knockdown inhibits gastric cancer progression.
Luo C; Yao Y; Yu Z; Zhou H; Guo L; Zhang J; Cao H; Zhang G; Li Y; Jiao Z
Oncotarget; 2017 May; 8(20):32639-32654. PubMed ID: 28427240
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-Conjugating Enzyme E2T is an Independent Prognostic Factor and Promotes Gastric Cancer Progression.
Yu H; Xiang P; Pan Q; Huang Y; Xie N; Zhu W
Tumour Biol; 2016 Sep; 37(9):11723-11732. PubMed ID: 27020591
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer.
Wen M; Kwon Y; Wang Y; Mao JH; Wei G
Oncotarget; 2015 Sep; 6(28):25226-39. PubMed ID: 26308072
[TBL] [Abstract][Full Text] [Related]
4. UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation.
Yin H; Wang X; Zhang X; Zeng Y; Xu Q; Wang W; Zhou F; Zhou Y
Cancer Lett; 2020 Dec; 494():121-131. PubMed ID: 32590022
[TBL] [Abstract][Full Text] [Related]
5. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
Hao P; Kang B; Li Y; Hao W; Ma F
Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis
Guo J; Wang M; Wang JP; Wu CX
World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276
[TBL] [Abstract][Full Text] [Related]
7. UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT.
Huang P; Guo Y; Zhao Z; Ning W; Wang H; Gu C; Zhang M; Qu Y; Zhang H; Song Y
Aging (Albany NY); 2020 Jun; 12(11):10275-10289. PubMed ID: 32491994
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of
Shen L; Zhao K; Li H; Ning B; Wang W; Liu R; Zhang Y; Zhang A
Epigenomics; 2019 Aug; 11(11):1283-1305. PubMed ID: 31355678
[No Abstract] [Full Text] [Related]
9. A novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination.
Yu Z; Jiang X; Qin L; Deng H; Wang J; Ren W; Li H; Zhao L; Liu H; Yan H; Shi W; Wang Q; Luo C; Long B; Zhou H; Sun H; Jiao Z
Oncogene; 2021 Feb; 40(5):1027-1042. PubMed ID: 33323973
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53.
Wu M; Li X; Huang W; Chen Y; Wang B; Liu X
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-conjugating enzyme E2T regulates cell proliferation and migration in cholangiocarcinoma.
Liu F; Zhu C; Gao P; Zheng S; Li C
Anticancer Drugs; 2020 Sep; 31(8):836-846. PubMed ID: 32796405
[TBL] [Abstract][Full Text] [Related]
12. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D
J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of UBE2T Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion by Suppressing the PI3K/Akt Signaling Pathway.
Wang Y; Leng H; Chen H; Wang L; Jiang N; Huo X; Yu B
Oncol Res; 2016; 24(5):361-369. PubMed ID: 27712593
[TBL] [Abstract][Full Text] [Related]
14. UBE2C induces EMT through Wnt/β‑catenin and PI3K/Akt signaling pathways by regulating phosphorylation levels of Aurora-A.
Wang R; Song Y; Liu X; Wang Q; Wang Y; Li L; Kang C; Zhang Q
Int J Oncol; 2017 Apr; 50(4):1116-1126. PubMed ID: 28260026
[TBL] [Abstract][Full Text] [Related]
15. UBE2T regulates epithelial-mesenchymal transition through the PI3K-AKT pathway and plays a carcinogenic role in ovarian cancer.
Cui P; Li H; Wang C; Liu Y; Zhang M; Yin Y; Sun Z; Wang Y; Chen X
J Ovarian Res; 2022 Sep; 15(1):103. PubMed ID: 36088429
[TBL] [Abstract][Full Text] [Related]
16. E2F5 promotes proliferation and invasion of gastric cancer through directly upregulating UBE2T transcription.
Li L; Liu J; Huang W
Dig Liver Dis; 2022 Jul; 54(7):937-945. PubMed ID: 34583905
[TBL] [Abstract][Full Text] [Related]
17. CHPF promotes gastric cancer tumorigenesis through the activation of E2F1.
Lin X; Han T; Xia Q; Cui J; Zhuo M; Liang Y; Su W; Wang L; Wang L; Liu Z; Xiao X
Cell Death Dis; 2021 Sep; 12(10):876. PubMed ID: 34564711
[TBL] [Abstract][Full Text] [Related]
18. UBE2T regulates FANCI monoubiquitination to promote NSCLC progression by activating EMT.
Zhang J; Wang J; Wu J; Huang J; Lin Z; Lin X
Oncol Rep; 2022 Aug; 48(2):. PubMed ID: 35703356
[TBL] [Abstract][Full Text] [Related]
19. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
[TBL] [Abstract][Full Text] [Related]
20. UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53.
Liu LP; Yang M; Peng QZ; Li MY; Zhang YS; Guo YH; Chen Y; Bao SY
Biochem Biophys Res Commun; 2017 Nov; 493(1):20-27. PubMed ID: 28935368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
